Despite the lack of deep value, there is something else: DarioHealth Corp (DRIO) Stock
Alliance Global Partners raised the price target for the DarioHealth Corp (NASDAQ:DRIO) stock from “a Neutral” to “a Buy”. The rating was released on May 13, 2022, according to finviz. The research report from Stifel has initiated the stock to Buy, with a price target set at $30. The stock was initiated by Cantor Fitzgerald, […]